Kitov Pharma (KTOV) Stock Rises 15.45%; Rated Strong Buy


Kitov Pharma (KTOV) stock is up more than 15% Friday, rising as high as $1.63, which is 48.2% higher than Thursday’s closing price of $1.10. KTOV stock is down -43.30% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives KTOV stock a score of 64 out of a possible 100.

That score is chiefly influenced by a fundamental score of 90. In addition to the average rating from Wall Street analysts, KTOV stock has a mean target price of $12.00. This means analysts expect the stock to increase 844.88% over the next 12 months. KTOV’s score also includes a short-term technical score of 55. The long-term technical score for KTOV is 46.

Click Here to get the full Stock Score Report on Kitov Pharma (KTOV).

What’s Happening with KTOV Stock Today

Kitov Pharma (KTOV) stock is up 15.45% while the S&P 500 is higher by 0.58% as of 2:00 PM on Friday, Apr 12. KTOV is higher by $0.17 from the previous closing price of $1.10 on volume of 21,474,064 shares. Over the past year the S&P 500 has gained 9.94% while KTOV is down -43.30%. KTOV lost -$0.07 per share in the over the last 12 months.

Symbols: KTOV

You May Also Like